While many studies propagate the inhibition of NLRP3, for example, by small molecule inhibitors such as MCC950, as a protective strategy after stroke [24,25], other data suggest a marginal role of NLRP3 after ischemic stroke. The gene discussed is NLRP3; the disease is stroke disorder.